People · Operator
Named in public records as an officer, director or promoter · active 2015–2025 · Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cyrus Biotechnology, Inc. | — | Biotech | Series B | $37.4M | $5.2M | 2015 |
Lucas Nivon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lucas Nivon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jason Smith | 1 | 14 |
| Chad Waite | 1 | 11 |
| Eric Bell | 1 | 7 |
| Gus Tai | 1 | 4 |
| MARK BENJAMIN | 1 | 3 |
| Ramakrishna Satyavolu | 1 | 2 |
| Javier Castellanos | 1 | 2 |
| Nivon Lucas | 1 | 1 |
| Yifan Song | 1 | 1 |
| Anthony Manning | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.